4 Cities for Assessing CAlcification PRognostic Impact After TAVI - Trial NCT02935491
Access comprehensive clinical trial information for NCT02935491 through Pure Global AI's free database. This phase not specified trial is sponsored by Hospices Civils de Lyon and is currently Completed. The study focuses on Heart Disease. Target enrollment is 1600 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Hospices Civils de Lyon
Timeline & Enrollment
N/A
Apr 01, 2016
Mar 01, 2017
Primary Outcome
Cardiovascular mortality
Summary
Transcatheter Aortic Valve Implantation (TAVI) indications are progressing rapidly as an
 alternative to conventional surgery for aortic stenosis cure. Despite a high rate of
 procedural success, some patients do not benefit from the procedure. The investigators
 hypothesis is that aortic stiffness may be of major prognostic significance after stenosis
 relief.
 
 The aim of this study is to test the prognostic impact of aortic stiffness estimated by the
 volume of calcifications of the thoracic aorta on the CT-scan performed systematically before
 the procedure. This prognostic value will be assessed in 4 independent cohorts issued from 4
 french cities (Lyon, Rouen, Paris, Clermont-Ferrand).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT02935491
Device Trial